EUVIMEDOpdag EUVIMED
Crossref

Glycopolymeric Micellar Nanoparticles for Platelet-Mediated Tumor-Targeted Delivery of Docetaxel for Cancer Therapy

Yan Zhang iD, Yi Li, Jieyu Gu, Jun Wu, Yongxin Ma, Guodong Lu, Mihail Barboiu iD, Jinghua Chen iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c09548 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2024. Written by Yan Zhang and 7 co-authors. Institution: Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Life Sciences and Health Engineering, Jiangnan Universit…. Major MEDLINE topics: Docetaxel, Micelles, Blood Platelets, Nanoparticles. Cited 12 times so far (Crossref); 46 references. Funded by: National Key Research and Development Program of China, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The high level of accumulation of therapeutic agents in tumors is crucial for cancer treatment. Compared to the passive tumor-targeting effect, active tumor-targeting delivery systems, primarily mediated by peptides with high production costs and reduced circulation time, are highly desired. Platelet-driven technologies have opened new avenues for targeted drug delivery prevalently through a membrane coating strategy that involves intricate manufacturing procedures or the fucoidan-mediated hitchhiking method with limited platelet affinity. Here, a novel type of amphiphilic glycopolymer self-assembled micellar nanoparticle has been developed to adhere to naturally activated platelets in the blood. The simultaneous integration of fucose and sialic acid segments into glycopolymers enables closer mimicry of the structure of P-selectin glycoprotein ligand-1 (PSGL-1), thereby increasing the affinity for activated platelets. It results in the formation of glycopolymeric micelle-platelet hybrids, facilitating targeted drug delivery to tumors. The selective platelet-assisted cellular uptake of docetaxel (DTX)-loaded glycopolymeric micelles leads to lower IC50 values against 4T1 cells than that of free DTX. The directed tumor-targeting effect of activated platelets has significantly improved the tumor accumulation capacity of the glycopolymeric nanoparticles, with up to 21.0% found in tumors within the initial 0.2 h. Additionally, with acid-responsive drug release and inherent antimetastasis properties, the glycopolymeric nanoparticles ensured potent therapeutic efficacy, prolonged survival time, and reduced cardiotoxicity, presenting a new and unexplored strategy for platelet-directed drug delivery to tumors, showing promising prospects in treating localized tumors and preventing tumor metastasis.

Subjects

MeSH terms (MEDLINE)

DocetaxelMicellesBlood PlateletsNanoparticlesAnimalsMiceCell Line, TumorAntineoplastic AgentsMice, Inbred BALB CHumansFemaleDrug Delivery SystemsDrug CarriersNeoplasms

Author keywords

cancer therapydrug deliveryglycopolymernanoparticlesplatelets

Substances

DocetaxelMicellesAntineoplastic AgentsDrug Carriers

Authors and institutions

  • Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, P. R. China.
  • Institut Europeen des Membranes, Adaptive Supramolecular Nanosystems Group, University of Montpellier, ENSCM-CNRS, UMR5635, Place E. Bataillon CC047, 34095 Montpellier, France.

ORCID profiles: Yan Zhang, Mihail Barboiu, Jinghua Chen

Funding

  • National Key Research and Development Program of China
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Cite

APA

Zhang, Y., Li, Y., Gu, J., Wu, J., Ma, Y., Lu, G., Barboiu, M., & Chen, J. (2024). Glycopolymeric Micellar Nanoparticles for Platelet-Mediated Tumor-Targeted Delivery of Docetaxel for Cancer Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c09548

Vancouver

Zhang Y, Li Y, Gu J, Wu J, Ma Y, Lu G, et al. Glycopolymeric Micellar Nanoparticles for Platelet-Mediated Tumor-Targeted Delivery of Docetaxel for Cancer Therapy. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c09548

BibTeX
@article{Zhang2024,
  author = {Zhang, Yan and Li, Yi and Gu, Jieyu and Wu, Jun and Ma, Yongxin and Lu, Guodong and Barboiu, Mihail and Chen, Jinghua},
  title = {Glycopolymeric Micellar Nanoparticles for Platelet-Mediated Tumor-Targeted Delivery of Docetaxel for Cancer Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c09548}
}
Start for free →